A NEW H-1-RECEPTOR ANTAGONIST, BW825C - EFFECTS ON TRACKING, REACTION-TIME AND SUBJECTIVE RATINGS

被引:0
|
作者
COHEN, AF [1 ]
HAMILTON, M [1 ]
STRUTT, A [1 ]
PHILIPSON, R [1 ]
PECK, AW [1 ]
机构
[1] WELLCOME RES LABS,DEPT CLIN PHARMACOL,BECKENHAM BR3 3BS,KENT,ENGLAND
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:P647 / P647
页数:1
相关论文
共 31 条
  • [21] ANTIALLERGIC EFFECTS OF THE NEW HISTAMINE H1-RECEPTOR ANTAGONIST TAZIFYLLINE IN HEALTHY ATOPIC AND NON-ATOPIC SUBJECTS
    RING, J
    GALOSI, A
    HARLOW, BJ
    REUTER, CA
    BIEBER, T
    RUZICKA, T
    YEE, KF
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1988, 38-1 (02): : 308 - 311
  • [22] Evidence for dopamine 'D-1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C
    Deveney, AM
    Waddington, JL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 317 (2-3) : 175 - 181
  • [23] BEHAVIORAL EVIDENCE FOR D-1-LIKE DOPAMINE-RECEPTOR SUBTYPES IN RAT-BRAIN USING THE NEW ISOCHROMAN AGONIST A-68930 AND ISOQUINOLINE ANTAGONIST BW-737C
    DALY, SA
    WADDINGTON, JL
    PSYCHOPHARMACOLOGY, 1993, 113 (01) : 45 - 50
  • [24] Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a1 receptor) antagonist
    Anliker-Ort, Marion
    Hsin, Chih-hsuan
    Krause, Andreas
    Pfister, Marc
    van den Anker, John
    Dingemanse, Jasper
    Kaufmann, Priska
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (04):
  • [25] Central effects of fexofenadine and cetirizine:: Measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography
    Tashiro, M
    Sakurada, Y
    Iwabuchi, K
    Mochizuki, H
    Kato, M
    Aoki, M
    Funaki, Y
    Itoh, M
    Iwata, R
    Wong, DF
    Yanai, K
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (08): : 890 - 900
  • [26] Effects of the Melatonin Receptor Antagonist (MT2)/Inverse Agonist (MT1) Luzindole on Re-entrainment of Wheel Running Activity and Spontaneous Homecage Behaviors in C3H/HeN Mice
    Adamah-Biassi, Ekue Bright
    Stepien, Iwona
    Hudson, Randall L.
    Dubocovich, Margarita L.
    FASEB JOURNAL, 2012, 26
  • [27] General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]1H-benzimidazole-7-carboxylate .1. Effects on central nervous system and other properties
    Kito, G
    Morimoto, S
    Shiomi, M
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1996, 46 (06): : 572 - 579
  • [28] Old and New Pharmacology: Positive Allosteric Modulation of the α7 Nicotinic Acetylcholine Receptor by the 5-Hydroxytryptamine2B/C Receptor Antagonist SB-206553 (3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b′]di pyrrole-1(2H)-carboxamide)
    Dunlop, John
    Lock, Tim
    Jow, Brian
    Sitzia, Fabrizio
    Grauer, Steven
    Jow, Flora
    Kramer, Angela
    Bowlby, Mark R.
    Randall, Andrew
    Kowal, Dianne
    Gilbert, Adam
    Comery, Thomas A.
    LaRocque, James
    Soloveva, Veronica
    Brown, Jon
    Roncarati, Renza
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (03): : 766 - 776
  • [29] EFFECTS OF THE NEW H-2-RECEPTOR ANTAGONIST 3-AMINO-4-[4-[4-(1-PIPERIDINOMETHYL)-2-PYRIDYLOXY]-CIS-2-BUTENYLAMINO]-3-CYCLOBUTENE-1,2-DIONE HYDROCHLORIDE ON GASTRIC-ACID SECRETION AND ULCERATION
    MURAMATSU, M
    ISOBE, Y
    ARAI, I
    HIROSEKIJIMA, H
    USUKIITO, C
    NAGAI, H
    AIHARA, H
    OTOMO, S
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1990, 40-1 (01): : 49 - 54
  • [30] Effects of the new angiotensin receptor antagonist dipotassium (Z)-2-[[5-ethyl-3-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl-1,3,4-thiadiazoline-2-ylidene]aminocarbonyl]-1-cyclopentencarboxylate on experimental cardiac hypertrophy and acute left ventricular failure
    Murakami, M
    Inada, Y
    Tazawa, S
    Nakao, K
    Komatsu, H
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1997, 47 (10): : 1099 - 1103